KELLY HALL: Open Payments
NPI 1881731917 · DEMOPOLIS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,540 in 20 payments from 11 companies in 2025. Trend: 2023 $91 · 2024 $22 · 2025 $1,540
Long term medical supply or device loan: $1,200Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. | 1 | $1,200 |
| PFIZER INC. | 5 | $84 |
| Amgen Inc. | 4 | $65 |
| Novo Nordisk Inc | 3 | $52 |
| United Therapeutics Corporation | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| Cleerly, Inc. | 1 | $16 |
Products named: VenaCure 1470 Pro, VYNDAQEL, REPATHA, Wegovy, Tyvaso, Kerendia, UPTRAVI, SHINGRIX.
Industry payments across AL — which companies pay providers there.
